Market Insights Health OTC Pharmaceuticals

Cold & Cough Remedies - Spain

Spain

In Spain, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to €0.71bn.
It is projected that the market will experience an annual growth rate of 6.00% (CAGR 2024-2029).
When comparing globally, the in the United States generates the highest revenue in this market, with a total of €10,380.00m in 2024.
In terms of per person revenues in Spain, it amounts to €15.01 in 2024 when considering the total population figures.
In Spain, there is a growing trend towards natural and herbal remedies for cold and cough, as consumers seek alternative options to traditional pharmaceuticals.

Key regions: Australia, Japan, India, Brazil, Canada

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Cold & Cough Remedies market in Spain has been experiencing steady growth in recent years.

Customer preferences: Spanish consumers have shown a growing preference for natural and herbal remedies for treating cold and cough symptoms. This shift in preference can be attributed to a general trend towards more natural and holistic approaches to healthcare. Consumers are increasingly seeking products that are perceived as safer and more gentle on the body, leading to a rise in demand for herbal remedies and homeopathic treatments.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Spain is the increasing popularity of combination products. These products offer multiple benefits in a single formulation, such as relieving congestion, soothing a sore throat, and reducing coughing. Combination products provide convenience to consumers who prefer to use a single product for multiple symptoms, and they have gained traction in the market as a result. Another trend in the market is the growing demand for over-the-counter (OTC) cold and cough remedies. As consumers become more proactive in managing their health, they are turning to OTC products for self-treatment of common ailments. OTC remedies offer convenience and accessibility, allowing consumers to address their cold and cough symptoms without the need for a doctor's prescription. This trend has contributed to the overall growth of the market in Spain.

Local special circumstances: One of the unique factors influencing the Cold & Cough Remedies market in Spain is the country's climate. Spain has a Mediterranean climate, characterized by mild winters and relatively warm temperatures throughout the year. This climate may contribute to a higher incidence of cold and cough symptoms, as people are more likely to spend time outdoors and come into contact with viruses. As a result, there is a constant demand for cold and cough remedies in the Spanish market.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in Spain is also influenced by macroeconomic factors. Spain has a large and aging population, which contributes to the demand for healthcare products, including cold and cough remedies. Additionally, the country has a well-developed healthcare system and a high level of healthcare expenditure, which supports the market growth. The increasing disposable income of Spanish consumers also plays a role in driving the demand for cold and cough remedies, as people are more willing to spend on self-care products. Overall, the Cold & Cough Remedies market in Spain is growing due to the preferences of consumers for natural and herbal remedies, the popularity of combination products, the demand for OTC remedies, the unique climate, and the underlying macroeconomic factors. These factors create a favorable environment for the growth of the market in Spain.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.